Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote — —   —
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  35.88 09:30 AM EST  
    Day High 37.17 11:44 AM EST
    Range 1.29  
    Volume 1.55 M  
    30-Day Avg Vol 797,000
    Difference 95.63%  
    Market Cap 2.38 B  
    Mkt Cap Chg 30.97 M  
    Shares Out 65.89 M  
    % Shrs Traded 2.37%  
    1yr EPS Est 2.17  
    52-Wk Low 23.031
    52-Wk High 40.14
    Range 17.11  
    Prev Close 35.69 2/8/10  
    Today's Open 35.88  
    Change 0.53%
    Dividend (TTM) 0.00  
    Div Yield (TTM) 0.00%
    Ex-Div Date —
    Div Date —
    Short Interest 3.4 M

    Performance Details

    Revenue (LFY) 1.34 B  
    Earnings (LFY) -521.84 M  
    Earnings (MRQ) 37.31 M  
    Next Earn Est 0.436  
    Next Earnings 05/03/2010
    EPS (TTM) -8.37  
    1yr EPS Growth -8.82%  
    P/E Ratio (TTM) —  
    P/E Ratio (Fwd) 16.00  
    PEG Ratio 1.60  
    Return on Equity -36.48  
    Beta 1.09  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
    More Details
  • Advertisement

  • Set and Manage Alerts

    Manage Alerts
    Alert me if
    Set Alert

  • Blog Posts: CRL

    Blogs are not currently available for crl.

    View all blogs at BloggingStocks.

  • Related Information: CRL

    Company Overview: CRL

    Charles River Laboratories International counts its chickens before they're hatched. The company provides clinical and laboratory research services and related products to pharmaceutical and biotech companies, ... View Full Description

    View Full Company Overview

    Earnings Analysis: CRL

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter 0.436 5/3/10 — — —
    —
    Last Quarter 0.436 12/31/09 0.49 12/31/09 0.054
    Beat
    2 Quarters Ago 0.602 9/30/09 0.65 9/30/09 0.048
    Beat
    View Full Earnings Analysis

    Financials: CRL

    Income Statement
      Quarterly - 09/26/2009 Annual - 2008
    Total Revenue 297.48 M 1.34 B
    Gross Profit 98.69 M 480.40 M
    Operating Income 46.90 M 250.24 M
    Net Income 37.31 M -521.84 M
    Financials: Balance Sheet | Cash Flow View All Financials

    Related Companies: CRL

    Sector: Healthcare      Industry: Drugs
    Symbol Name Price Change
    CVD COVANCE INC 55.13 -0.30 -0.54%